US2010173849A1PendingUtilityA1

Neo-tryptophan

57
Assignee: RICHELSON ELLIOTTPriority: Apr 10, 1998Filed: Jan 4, 2010Published: Jul 8, 2010
Est. expiryApr 10, 2018(expired)· nominal 20-yr term from priority
Inventors:Elliott RichelsonBernadette Marie CusackYuan-Ping PangDaniel J. MccormickAbdul FauqBeth Marie TylerMona Boules
C07D 209/08C07K 7/18C07K 14/702C07K 14/70A61P 25/04C07K 7/083C07K 7/14A61P 29/00A61K 38/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77.

Claims

exact text as granted — not AI-modified
1 . A method of inducing antinociception in a human, said method comprising administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. 
   
   
       2 . The method of  claim 1 , wherein the polypeptide is selected from the group consisting of NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, and NT77.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.